Tirzepatide Therapy

What Is Tirzepatide?

Tirzepatide (Mounjaro/Zepbound) is a dual-action GIP and GLP-1 receptor agonist that has shown up to 22% body weight reduction in clinical trials — outperforming semaglutide in head-to-head studies. Compounded tirzepatide at longevity clinics is typically more affordable than commercial Zepbound.

Key Benefits

• ✓ Up to 22% body weight reduction
• ✓ Dual hormone action (GIP + GLP-1)
• ✓ Stronger appetite suppression than semaglutide
• ✓ Improved metabolic markers
• ✓ Potential cardiovascular benefits

Questions to Ask Your Clinic

Before starting any Tirzepatide protocol, ask these questions — the answers reveal a lot about the clinic's quality and approach.

• ❓ What compounding pharmacy do you use?
• ❓ Do you monitor labs throughout the protocol?
• ❓ What happens if I plateau?
• ❓ Is tirzepatide or semaglutide better for my profile?